The Schall Law Firm Urges Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics Inc
Portfolio Pulse from
The Schall Law Firm is urging shareholders with losses to join a securities fraud case against Applied Therapeutics Inc. The lawsuit alleges violations of the Securities Exchange Act of 1934. Investors who purchased securities between January 3, 2024, and December 2, 2024, are encouraged to contact the firm by February 18, 2025.
December 31, 2024 | 4:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Applied Therapeutics Inc. is facing a class action lawsuit for alleged securities fraud, which could negatively impact its stock price. Shareholders who incurred losses are encouraged to join the lawsuit.
The announcement of a class action lawsuit for securities fraud against Applied Therapeutics is likely to negatively impact investor sentiment and the stock price in the short term. Legal issues of this nature can lead to increased volatility and uncertainty, prompting investors to reassess their positions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100